67 related articles for article (PubMed ID: 27731537)
1. Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Mencacci NE; Isaias IU; Reich MM; Ganos C; Plagnol V; Polke JM; Bras J; Hersheson J; Stamelou M; Pittman AM; Noyce AJ; Mok KY; Opladen T; Kunstmann E; Hodecker S; Münchau A; Volkmann J; Samnick S; Sidle K; Nanji T; Sweeney MG; Houlden H; Batla A; Zecchinelli AL; Pezzoli G; Marotta G; Lees A; Alegria P; Krack P; Cormier-Dequaire F; Lesage S; Brice A; Heutink P; Gasser T; Lubbe SJ; Morris HR; Taba P; Koks S; Majounie E; Raphael Gibbs J; Singleton A; Hardy J; Klebe S; Bhatia KP; Wood NW;
Brain; 2014 Sep; 137(Pt 9):2480-92. PubMed ID: 24993959
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.
Nagatsu T
J Neural Transm (Vienna); 2024 Jun; 131(6):617-630. PubMed ID: 37638996
[TBL] [Abstract][Full Text] [Related]
3. Three-Dimensional Gait Analysis as a Biomarker for GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia.
Narahara S; Ochi N; Ito Y; Ito T; Narita H; Noritake K; Kidokoro H; Natsume J
Pediatr Neurol; 2024 May; 154():66-69. PubMed ID: 38547557
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of dopa-responsive dystonia and related disorders.
Lee WW; Jeon BS
Curr Neurol Neurosci Rep; 2014 Jul; 14(7):461. PubMed ID: 24844652
[TBL] [Abstract][Full Text] [Related]
5. Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike.
Lee WW; Jeon B; Kim R
J Korean Med Sci; 2018 Jul; 33(28):e184. PubMed ID: 29983692
[TBL] [Abstract][Full Text] [Related]
6. Atypical presentation of dopa-responsive dystonia in Taiwan.
Weng YC; Wang CC; Wu YR
Brain Behav; 2018 Feb; 8(2):e00906. PubMed ID: 29484265
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
Rose SJ; Harrast P; Donsante C; Fan X; Joers V; Tansey MG; Jinnah HA; Hess EJ
Mov Disord; 2017 Dec; 32(12):1694-1700. PubMed ID: 28949038
[TBL] [Abstract][Full Text] [Related]
8. An Inversion Affecting the GCH1 Gene as a Novel Finding in Dopa-Responsive Dystonia.
El-Wahsh S; Fellner A; Hobbs M; Copty J; Deveson I; Stevanovski I; Stoll M; Zhu D; Narayanan RK; Grosz B; Worgan L; Cheong PL; Yeow D; Rudaks L; Hasan MM; Hayes VM; Kennerson M; Kumar KR; Hayes M
Mov Disord Clin Pract; 2024 May; 11(5):582-585. PubMed ID: 38497520
[No Abstract] [Full Text] [Related]
9. Older-onset levodopa-responsive parkinsonism with normal DAT-SPECT and pterin hypometabolism.
Togo K; Ishihara T; Yamamoto K; Sawada H
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33962918
[TBL] [Abstract][Full Text] [Related]
10. [Anesthesia in patients with dopa-responsive dystonia (Segawa syndrome) : Presentation of the pathophysiology, clinical picture and approach based on two case reports].
Groß K; Kleinschmidt S
Anaesthesist; 2021 Apr; 70(4):316-319. PubMed ID: 33294947
[TBL] [Abstract][Full Text] [Related]
11. Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
Bally JF; Breen DP; Schaake S; Trinh J; Rakovic A; Klein C; Lang AE
Parkinsonism Relat Disord; 2020 Feb; 71():44-45. PubMed ID: 32018151
[TBL] [Abstract][Full Text] [Related]
12. Segawa Syndrome, a Dramatic Response to Dopamine.
Dhungel O; Shrestha A; Sharma P; Sapkota N; Paudel R
Case Rep Neurol Med; 2024; 2024():8154006. PubMed ID: 38590786
[TBL] [Abstract][Full Text] [Related]
13. Reversible MRI brain changes in hypermanganesaemia with dystonia 1 with EDTA therapy.
Chawla T; Sehgal J; Goyal V
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35688573
[No Abstract] [Full Text] [Related]
14. Transcranial Sonography Characteristics of Cerebellar Neurodegenerative Ataxias.
Tamaš O; Mijajlović M; Švabić T; Kostić M; Marić G; Milovanović A; Jeremić M; Dragašević-Mišković N
Brain Sci; 2024 Mar; 14(4):. PubMed ID: 38671992
[TBL] [Abstract][Full Text] [Related]
15. Is Generalized and Segmental Dystonia Accompanied by Impairments in the Dopaminergic System?
Ikezawa J; Yokochi F; Okiyama R; Kumada S; Tojima M; Kamiyama T; Hanakawa T; Matsuda H; Tanaka F; Nakata Y; Isozaki E
Front Neurol; 2021; 12():751434. PubMed ID: 34867735
[No Abstract] [Full Text] [Related]
16. Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson's Disease and Other Movement Disorders: A Meta-Analysis.
Mei YL; Yang J; Wu ZR; Yang Y; Xu YM
Parkinsons Dis; 2021; 2021():8891874. PubMed ID: 34007439
[TBL] [Abstract][Full Text] [Related]
17. Transcranial sonography in dopa-responsive dystonia.
Svetel M; Tomić A; Mijajlović M; Dobričić V; Novaković I; Pekmezović T; Brajković L; Kostić VS
Eur J Neurol; 2017 Jan; 24(1):161-166. PubMed ID: 27731537
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
